NR4A1 and cancer: Compared to clinically applicable GWs, (Z)-BP in CW can not only reduce nuclear receptor subfamily 4 group A member 1 (Nur77) to increase cancer cell apoptosis [35], but also inhibit telomerase reverse transcriptase (TERT) to promote cell senescence [28].